Loading
EMV Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest was filed 23 Apr 2026.
EMV: what insiders have been doing
Only a handful of insider records exist for EMV, the last one from 23 April 2026, too few to describe a trend. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€11,293
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleCarmel Monaghan1 buy
Since the insiders bought
- -15.2%Entry A$1.74 · Close at T+90 A$1.48
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended June 2025 · cache
A$1.80
Analyst consensus
1 analysts1.00/5
A$3.15Target A$3.15(+75%)A$3.15
Income statement
EBITDA-A$7.9M
Net income-A$9.8M-188.0% margin
Valuation
PER (forward)-15.9x
P/Book8.5x
Beta1.05
Balance sheet & cash
Market capA$166.8M
Total debtA$3.5M
Free Cash Flow-A$7.9M
Debt / Equity18%
Profitability & ownership
ROE-58.0%
ROA-26.6%
% insiders33.2%
% institutions2.6%
Last declaration on 23 April 2026
Declarations1 total
10,000 shares@ A$1.8470.011% mcap100.0% of flowShareASXASX:2924-03082181-6A1321889
Canonical exit: 21 Jul 2026 (T+90)
1 of 1 declaration
About EMV
EMV is a company in the healthcare and pharmaceutical sector, listed on the XASX market. It specializes in developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
